1 |
Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). [J]. Eur Heart J, 2014, 35(39): 2733-2779.
|
2 |
Mor-Avi V, Lang RM, Badano LP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography [J]. J Am Soc Echocardiogr, 2011, 24(3): 277-313.
|
3 |
Blessberger H, Binder T. NON-invasive imaging: two dimensional speckle tracking echocardiography: basic principles [J]. Heart, 2010, 96(9): 716-722.
|
4 |
Seo Y, Ishizu T, Aonuma K. Current status of 3-dimensional speckle tracking echocardiography: a review from our experiences [J]. J Cardiovasc Ultrasound, 2014, 22(2): 49-57.
|
5 |
Ishizu T, Seo Y, Enomoto Y, et al. Experimental validation of left ventricular transmural strain gradient with echocardiographic two-dimensional speckle tracking imaging [J]. Eur J Echocardiogr, 2010, 11(4): 377-385.
|
6 |
Ho CY. Hypertrophic cardiomyopathy: preclinical and early phenotype [J]. J Cardiovasc Transl Res, 2009, 2(4): 462-470.
|
7 |
Huang X, Yue Y, Wang Y, et al. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging [J]. Cardiovasc Ultrasound, 2018, 16(1): 23.
|
8 |
Grover S, Lloyd R, Perry R, et al. Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study [J]. Eur Heart J Cardiovasc Imaging, 2019, 20(8): 932-938.
|
9 |
Pagourelias ED, Mirea O, Vovas G, et al. Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidois: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis [J]. Eur Heart J Cardiovasc Imaging, 2019, 20(4): 426-437.
|
10 |
Hiemstra YL, van der Bijl P, El Mahdiui M, et al. Myocardial Work in nonobstructive hypertrophic cardiomyopathy: implications for outcome [J]. J Am Soc Echocardiogr, 2020, 33(10): 1201-1208.
|
11 |
Liu W, Zhang Y, Liu Y, et al. Assessment of left ventricular systolic function in hypertrophic cardiomyopathy patients with myocardial injury: a study based on layer-specific speckle tracking echocardiaography [J]. Int J Cardiovasc Imaging, 2020, 36(11): 2129-2137.
|
12 |
Park SJ, Miyazaki C, Bruce CJ, et al. Left ventricular torsion by two-dimensional speckle tracking echocardiography in patients with diastolic dysfunction and normal ejection fraction [J]. J Am Soc Echocardiogr, 2008, 21(10): 1129-1137.
|
13 |
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging [J]. J Am Soc Echocardiogr, 2016, 29(4): 277-314.
|
14 |
Chen S, Yuan J, Qiao S, et al. Evaluation of left ventricular diastolic function by global strain rate imaging in patients with obstructive hypertrophic cardiomyopathy: a simultaneous speckle tracking echocardiography and cardiac catheterization study [J]. Echocardiography, 2014, 31(5): 615-622.
|
15 |
Garceau P, Carasso S, Woo A, et al. Evaluation of left ventricular relaxation and filling pressures in obstructive hypertrophic cardiomyopathy: comparison between invasive hemodynamics and two-dimensional speckle tracking [J]. Echocardiography, 2012, 29(8): 934-942.
|
16 |
Domsik P, Kalapos A, Chadaide S, et al. Three-dimensional speckle tracking echocardiography allows detailed evaluation of left atrial function in hypertrophic cardiomyopathy--insights from the MAGYAR-Path study [J]. Echocardiography, 2014, 31(10): 1245-1252.
|
17 |
Huang J, Yan ZN, Rui YF, et al. Assessment of left atrial function in patients with hypertrophic cardiomyopathy using two-dimensional strain: a comparison with volume-derived values [J]. Minerva Cardioangiol, 2018, 66(1): 26-37.
|
18 |
Kim KJ, Choi HM, Yoon YE, et al. Left atrial mechanical function and global strain in hypertrophic cardiomyopathy [J]. PLoS One, 2016, 11(6): e0157433.
|
19 |
Fujimoto K, Inoue K, Saito M, et al. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy [J]. Echocardiography, 2018, 35(8): 1138-1148.
|
20 |
Hensley N, Dietrich J, Nyhan D, et al. Hypertrophic cardiomyopathy: a review [J]. Anesth Analg, 2015, 120(3): 554-569.
|
21 |
Limongelli G, Masarone D, Frisso G, et al. Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement [J]. J Cardiovasc Med (Hagerstown), 2017, 18(4): 249-254.
|
22 |
Rai AB, Lima E, Munir F, et al. Speckle tracking echocardiography of the right atrium: the neglected chamber [J]. Clin Cardiol, 2015, 38(11): 692-697.
|
23 |
Huang J, Yang C, Ni CF, et al. Right atrial function assessed by volume-derived values and speckle tracking echocardiography in patients with hypertrophic cardiomyopathy [J]. BMC Cardiovasc Disord, 2020, 20(1): 335.
|
24 |
Finocchiaro G, Knowles JW, Pavlovic A, et al. Prevalence and clinical correlates of right ventricular dysfunction in patients with hypertrophic cardiomyopathy [J]. Am J Cardiol, 2014, 113(2): 361-367.
|
25 |
Hiemstra YL, Debonnaire P, Bootsma M, et al. Prevalence and prognostic implications of right ventricular dysfunction in patients with hypertrophic cardiomyopathy [J]. Am J Cardiol, 2019, 124(4): 604-612.
|
26 |
Cincin A, Tigen K, Karaahmet T, et al. Right ventricular function in hypertrophic cardiomyopathy: a speckle tracking echocardiography study [J]. Anatol J Cardiol, 2015, 15(7): 536-541.
|
27 |
Funabashi N, Takaoka H, Ozawa K, et al. Quantitative differentiation of LV myocardium with and without layer-specific fibrosis using MRI in hypertrophic cardiomyopathy and layer-specific strain TTE analysis [J]. Int Heart J, 2018, 59(3): 523-530.
|
28 |
Funabashi N, Takaoka H, Ozawa K, et al. Endocardial fibrotic lesions have a greater effect on peak longitudinal strain than epicardial fibrotic lesions in hypertrophic cardiomyopathy patients [J]. Int Heart J, 2018, 59(2): 347-353.
|
29 |
Galli E, Vitel E, Schnell F, et al. Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis [J]. Echocardiography, 2019, 36(1): 74-82.
|
30 |
Fang H, Tang H, Li P, et al. An assessment of left atrial function in patients with hypertrophic obstructive cardiomyopathy before and 1 year after septal ablation by two-dimensional speckle tracking echocardiography [J]. Echocardiography, 2017, 34(3): 407-414.
|
31 |
Weissler-Snir A, Hindieh W, Moravsky G, et al. Left atrial remodeling postseptal myectomy for severe obstructive hypertrophic cardiomyopathy: analysis by two-dimensional speckle-tracking echocardiography [J]. Echocardiography, 2019, 36(2): 276-284.
|
32 |
Elliott PM, Gimeno JR, Thaman R, et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy [J]. Heart, 2006, 92(6): 785-791.
|
33 |
Vergé MP, Cochet H, Reynaud A, et al. Characterization of hypertrophic cardiomyopathy according to global, regional, and multi-layer longitudinal strain analysis, and prediction of sudden cardiac death [J]. Int J Cardiovasc Imaging, 2018, 34(7): 1091-1098.
|
34 |
Zhao J, Wang J, Liu LW, et al. The role of three-dimensional speckle tracking imaging derived parameters on predicting outcome of hypertrophic cardiomyopathy patients with MYH7 mutations [J]. Zhonghua Xin Xue Guan Bing Za Zhi, 2020, 48(4): 287-293.
|
35 |
Candan O, Gecmen C, Kalaycı A, et al. Left ventricular twist in hypertrophic cardiomyopathy : predictor of nonsustained ventricular tachycardia [J]. Herz, 2019, 44(3): 238-246.
|